Market drivers are instrumental in steering the growth trajectory of the lenalidomide drug market. Among these drivers is the increasing incidence of hematologic malignancies, where lenalidomide plays a pivotal role in treatment regimens. Moreover, advancements in research and development activities contribute to the expansion of lenalidomide's therapeutic applications, driving market growth....
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian